PECORARO, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 394
EU - Europa 323
AS - Asia 189
AF - Africa 18
Totale 924
Nazione #
US - Stati Uniti d'America 378
IT - Italia 260
SG - Singapore 121
CN - Cina 26
VN - Vietnam 24
CA - Canada 16
CI - Costa d'Avorio 16
NL - Olanda 12
RU - Federazione Russa 12
GB - Regno Unito 9
SE - Svezia 7
DE - Germania 6
JP - Giappone 5
BG - Bulgaria 4
KR - Corea 4
HK - Hong Kong 3
FI - Finlandia 2
FR - Francia 2
IE - Irlanda 2
IN - India 2
LV - Lettonia 2
MA - Marocco 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
NO - Norvegia 1
PL - Polonia 1
TR - Turchia 1
Totale 924
Città #
Naples 107
Santa Clara 105
Singapore 99
Chandler 86
Orta di Atella 43
Dong Ket 24
Millbury 16
Ashburn 13
Lawrence 13
Ottawa 12
Amsterdam 10
Rome 9
Des Moines 8
Formia 8
Nanjing 6
Napoli 6
Houston 5
London 5
Milan 5
Seattle 5
Chuo 4
Ercolano 4
Portici 4
Reggio Emilia 4
Sofia 4
Venice 4
Giugliano in Campania 3
Guangzhou 3
Hong Kong 3
Leipzig 3
Lioni 3
Redwood City 3
Wilmington 3
Acerra 2
Boston 2
Cagliari 2
Carife 2
Casablanca 2
Caserta 2
Castello di Cisterna 2
Crane Hill 2
Dublin 2
Edinburgh 2
Jinhua 2
Los Angeles 2
Milwaukee 2
Moscow 2
Paris 2
Riga 2
Roccarainola 2
San Biagio di Callalta 2
Seoul 2
Shenyang 2
Toronto 2
Amgaon 1
Athens 1
Bari 1
Borås 1
Chicago 1
Chongqing 1
Crispano 1
Dallas 1
Dubai 1
Fairfield 1
Gyeyang-gu 1
Hangzhou 1
Hebei 1
Helsinki 1
Huaibei 1
Lappeenranta 1
Marano Di Napoli 1
Mashhad 1
Matera 1
Montreal 1
Mumbai 1
Nanchang 1
Newark 1
Nola 1
Norwalk 1
Philadelphia 1
San Cipriano d'Aversa 1
Sandston 1
Santa Cruz de Tenerife 1
Sapri 1
Serrara Fontana 1
Shanghai 1
Shenzhen 1
Shoham 1
Tokyo 1
Turi 1
Volla 1
Wandsworth 1
Warsaw 1
Washington 1
Zurich 1
Totale 713
Nome #
UL3 mediated nucleolar stress pathway as a new mechanism of action of antiproliferative G-quadruplex TBA derivatives in colon cancer cells 62
Antiproliferative Effects of the Aptamer d(GGGT) 4 and Its Analogues with an Abasic-Site Mimic Loop on Different Cancer Cells 56
Role of uL3 in the crosstalk between nucleolar stress and autophagy in colon cancer cells 53
Role of rpL3 in the translational reprogramming of colon cancer cells resistant to 5-FU” 50
Ribosomal protein uL3 targets E2F1 and Cyclin D1 in cancer cell response to nucleolar stress 50
Ribosome-free L3 targets E2F pathway: a new p53 independent mechanism linking ribosomal stress to cancer cell proliferation 47
Role of autophagy in cancer cell response to nucleolar and endoplasmic reticulum stress 47
Therapeutic Approaches Targeting Nucleolus in Cancer. 46
Structural properties and anticoagulant/cytotoxic activities of heterochiral enantiomeric thrombin binding aptamer (TBA) derivatives 46
Exploring New Potential Anticancer Activities of the G-Quadruplexes Formed by [(GTG2T(G3T)3] and Its Derivatives with an Abasic Site Replacing Single Thymidine 44
L3 is involved in the translational reprogramming in 5-FU chemoresistance” ABCD Meeting: From Stress Response to Tissue Development and Regeneration. 38
Ribosome-free L3 regulates cell proliferation independently of p53 by targeting E2F and inhibiting its function 34
Ribosome biogenesis and cancer: Overview on ribosomal proteins 33
Development and Nanoparticle-Mediated Delivery of Novel MDM2/MDM4 Heterodimer Peptide Inhibitors to Enhance 5-Fluorouracil Nucleolar Stress in Colorectal Cancer Cells 31
S-Adenosyl-L-Methionine Overcomes uL3-Mediated Drug Resistance in p53 Deleted Colon Cancer Cells 31
Combining β-Carotene with 5-FU via Polymeric Nanoparticles as a Novel Therapeutic Strategy to Overcome uL3-Mediated Chemoresistance in p53-Deleted Colorectal Cancer Cells 29
β3 Relaxant Effect in Human Bladder Involves Cystathionine γ-Lyase-Derived Urothelial Hydrogen Sulfide 29
Vitamin C enhanced erastin-induced ferroptosis in drug-resistant colorectal cancer cells and in CAM-derived xenografts 26
Novel Molecular Mechanisms Underlying Tumorigenesis and Innovative Therapeutic Approaches for Cancer-Fighting 25
Targeting SLC7A11/xCT counteracts uL3mediated colorectal cancer drug resistance in 2D cell culture model and in ovo CAM xenograft 19
uL3 status influences ferroptotic cell death in p53-deleted colorectal cancer cells 18
β-carotene as a novel adjuvant in the therapy with 5-FU of p53 deleted colon cancer cells 15
uL3 loss sensitize resistant p53 deleted colon cancer cells to ferroptosis 14
β-carotene plus 5-FU: a promising strategy to fight uL3-mediated drug resistance in colorectal cancer cells 13
Role of uL3 in the translational reprogramming of 5-FU resistant colorectal cancer cells lacking functional p53 13
Ribosomal protein uL3 is involved in translational reprogramming of 5-FU resistant colorectal cancer cells 12
Combination therapy with β-carotene+5-FU to overcome uL3-mediated drug resistance in p53 deleted colon cancer cells 11
S-Adenosyl-l-Methionine: a strategy for overcoming uL3-mediated drug resistance in p53 deleted colon cancer cells 11
G-Quadruplex aptamer T30175 and its derivatives: exploring new potential anticancer activities 11
uL3 Regulates Redox Metabolism and Ferroptosis Sensitivity of p53-Deleted Colorectal Cancer Cells 11
Combination of 5-FU and MDM2/4 peptide inhibitors as a promising strategy to enhance 5-FU induced nucleolar stress. 10
Fetal Myosin Isoforms May Predict Postoperative Outcome of Patients Undergoing Congenital Heart Surgery: A Proof-of-Concept Study 10
Ribosomal protein uL3 status affects translation efficiency in colorectal cancer cells 9
Non-covalent strategies to functionalize polymeric nanoparticles with NGR peptides for targeting breast cancer 9
Ribosomal protein uL3 as regulator of ferroptosis in 5-FU resistance 9
Cystine/glutamate exchanger xCT plays a critical role in uL3-mediated drug resistance 8
Novel therapeutic strategy combining β-carotene with 5-FU to overcome uL3-mediated chemoresistance in colorectal cancer cells 8
Impact of ribosomal protein uL3 status on cystine/glutamate antiporter xCT expression 7
Enhanced 5-FU-mediated activation of p53-dependent nucleolar stress by MDM2/4 peptide inhibitors in colon cancer cells 6
Novel uL3-based Therapeutic Approaches to Treat Colon Cancer Devoid of p53 6
MDM2/4 inhibitors as novel therapeutic strategy to enhance 5-FU induced nucleolar stress and apoptosis in colon cancer cells 5
Totale 1.012
Categoria #
all - tutte 4.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028 0 0 0 0 0 0 2 0 0 1 2 23
2020/202164 4 0 0 0 5 20 1 4 5 1 0 24
2021/202276 0 0 3 5 3 13 3 5 1 11 2 30
2022/2023244 17 17 10 8 26 36 3 40 56 11 16 4
2023/2024151 5 18 13 2 6 31 9 19 2 7 22 17
2024/2025423 29 29 3 148 74 140 0 0 0 0 0 0
Totale 1.012